Cresco Labs Inc. (OTCMKTS:CRLBF) Receives Consensus Recommendation of “Buy” from Analysts

Cresco Labs Inc. (OTCMKTS:CRLBF) has received an average rating of “Buy” from the four brokerages that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and two have assigned a strong buy recommendation to the company.

Separately, Cormark upgraded shares of Cresco Labs from a “hold” rating to a “moderate buy” rating in a report on Monday, March 17th.

Cresco Labs Stock Down 5.4%

Shares of OTCMKTS:CRLBF opened at $0.68 on Monday. Cresco Labs has a 52-week low of $0.52 and a 52-week high of $2.30. The company has a market capitalization of $334.63 million, a PE ratio of -3.41 and a beta of 1.73. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97. The company has a fifty day moving average of $0.71 and a 200-day moving average of $0.90.

Cresco Labs (OTCMKTS:CRLBF) last issued its earnings results on Friday, March 14th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01). Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The business had revenue of $176.00 million during the quarter, compared to analysts’ expectations of $172.10 million. On average, equities analysts predict that Cresco Labs will post -0.2 EPS for the current fiscal year.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.